Aditya Karthikeyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aditya Karthikeyan has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Adir Alper
Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY
2 shared publications- Sharanya Kaushik
Department of Medicine, Jacobi Medical Center, Bronx, New York
2 shared publications Sridhar Mangalesh
2 shared publications- Afthab Salam Kanniyan
Government Medical College, Kozhikode, India
1 shared publication Amrin Kharawala
Division of Cardiology, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
1 shared publication- Ana-Cătălina Dascălu
Spitalul Clinic Judetean de Urgenta Târgu Mureş, Târgu Mureş, Romania
1 shared publication
Latest Publications
- 2 November 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
Supplement Use and Diet Quality Among U.S. Adults by Eligibility for Lipid-Lowering Therapy
Background: The 2026 American Heart Association/ American College of Cardiology (AHA/ACC) dyslipidemia guideline advises against supplements for lipid lowering. Whether supplement use reflects broader engagement in cardiovascular prevention, including healthy eating, remains uncertain. We examined supplement use and selected dietary characteristics across lipid-lowering therapy (LLT) treatment and eligibility groups. Methods: We conducted a cross-sectional analysis of National Health and Nutrition Examination Survey data (2015-2020) from adults aged 30-75 years. Participants were classified as current LLT users or untreated adults. Untreated adults were further classified as recommended, reasonable/selectively consider, or not routinely recommended for LLT, using the 2026 AHA/ACC guideline. Outcomes were self-reported heart health or cholesterol supplement use and dietary misalignment burden, defined as the number of unmet benchmarks across nine selected recall-day indicators informed by 2026 AHA dietary guidance. Analyses incorporated the complex survey design and fasting subsample weights to generate national estimates and compare supplement use across burden categories. Results: We analyzed 3,743 participants, representing 147.3 million US adults; 49.0% were female, and 25.0% were receiving LLT. Overall, 11.3% [9.4-13.6] reported supplement use. Supplement use was highest among adults receiving LLT (19.5% [14.9-25.1]) and lowest among untreated adults for whom LLT was not routinely recommended (3.6% [2.6-5.1]). Among untreated adults for whom LLT was recommended, 4.2 million (12.8% [10.5-15.4]) used supplements. Dietary inadequacies were common across measured domains and LLT eligibility strata; the weighted median misalignment burden was 7 (IQR 6-8). Supplement use did not differ significantly across dietary misalignment burden categories. Conclusions: Millions of US adults recommended for LLT were untreated while using heart health or cholesterol supplements, and supplement use did not differ significantly across selected dietary misalignment burden categories. Proactive assessment of supplement use may help redirect prevention counseling toward guideline-directed LLT and heart-healthy dietary patterns.
- 2 November 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
Supplement Use and Diet Quality Among U.S. Adults by Eligibility for Lipid-Lowering Therapy
Background: The 2026 American Heart Association/ American College of Cardiology (AHA/ACC) dyslipidemia guideline advises against supplements for lipid lowering. Whether supplement use reflects broader engagement in cardiovascular prevention, including healthy eating, remains uncertain. We examined supplement use and selected dietary characteristics across lipid-lowering therapy (LLT) treatment and eligibility groups. Methods: We conducted a cross-sectional analysis of National Health and Nutrition Examination Survey data (2015-2020) from adults aged 30-75 years. Participants were classified as current LLT users or untreated adults. Untreated adults were further classified as recommended, reasonable/selectively consider, or not routinely recommended for LLT, using the 2026 AHA/ACC guideline. Outcomes were self-reported heart health or cholesterol supplement use and dietary misalignment burden, defined as the number of unmet benchmarks across nine selected recall-day indicators informed by 2026 AHA dietary guidance. Analyses incorporated the complex survey design and fasting subsample weights to generate national estimates and compare supplement use across burden categories. Results: We analyzed 3,743 participants, representing 147.3 million US adults; 49.0% were female, and 25.0% were receiving LLT. Overall, 11.3% [9.4-13.6] reported supplement use. Supplement use was highest among adults receiving LLT (19.5% [14.9-25.1]) and lowest among untreated adults for whom LLT was not routinely recommended (3.6% [2.6-5.1]). Among untreated adults for whom LLT was recommended, 4.2 million (12.8% [10.5-15.4]) used supplements. Dietary inadequacies were common across measured domains and LLT eligibility strata; the weighted median misalignment burden was 7 (IQR 6-8). Supplement use did not differ significantly across dietary misalignment burden categories. Conclusions: Millions of US adults recommended for LLT were untreated while using heart health or cholesterol supplements, and supplement use did not differ significantly across selected dietary misalignment burden categories. Proactive assessment of supplement use may help redirect prevention counseling toward guideline-directed LLT and heart-healthy dietary patterns.
- Open Access
State-Level Promotion of Plant-Based School Meals in the United States: A National Policy Review
Background: Pediatric cardiometabolic health in the United States is declining, driven by rising rates of obesity, prediabetes, and type 2 diabetes. School lunch programs provide a unique opportunity to influence children’s dietary behaviors, reaching millions of students across diverse socioeconomic backgrounds each day. Increasing the availability of plant-based meals in school lunch programs may help reduce modifiable cardiometabolic risk factors and serve as a cost-effective, population-level strategy to promote long-term cardiovascular health. Methods: We conducted a cross-sectional narrative policy review of school lunch programs across all 50 U.S. states and the District of Columbia. Publicly available state statutes, regulations, school nutrition guidance, government reports, and educational resources were systematically reviewed to identify official statewide policies or guidance explicitly supporting plant-based or vegetarian meals. Jurisdictions were classified as providing either Explicit Support or Not Specified according to predefined coding criteria. We also assessed whether jurisdictions specified the frequency of plant-based meal offerings. Results: Only 3 of 51 jurisdictions (5.9%)—California, the District of Columbia, and Illinois—provided explicit statewide support for plant-based meal options. The remaining 48 jurisdictions (94.1%) did not explicitly promote or support plant-based meals in official statewide school nutrition policies or guidance. No jurisdiction mandated the frequency of plant-based meal offerings, although the District of Columbia provided non-binding guidance encouraging regular inclusion. Conclusions: Explicit statewide support for plant-based or vegetarian school meals remains rare in the United States. Strengthening state-level policies and developing standardized guidance on the inclusion and frequency of plant-based meals in school lunch programs may represent a feasible population-level strategy to improve dietary quality and reduce future pediatric cardiometabolic risk.
Open AccessState-Level Promotion of Plant-Based School Meals in the United States: A National Policy Review
Background: Pediatric cardiometabolic health in the United States is declining, driven by rising rates of obesity, prediabetes, and type 2 diabetes. School lunch programs provide a unique opportunity to influence children’s dietary behaviors, reaching millions of students across diverse socioeconomic backgrounds each day. Increasing the availability of plant-based meals in school lunch programs may help reduce modifiable cardiometabolic risk factors and serve as a cost-effective, population-level strategy to promote long-term cardiovascular health. Methods: We conducted a cross-sectional narrative policy review of school lunch programs across all 50 U.S. states and the District of Columbia. Publicly available state statutes, regulations, school nutrition guidance, government reports, and educational resources were systematically reviewed to identify official statewide policies or guidance explicitly supporting plant-based or vegetarian meals. Jurisdictions were classified as providing either Explicit Support or Not Specified according to predefined coding criteria. We also assessed whether jurisdictions specified the frequency of plant-based meal offerings. Results: Only 3 of 51 jurisdictions (5.9%)—California, the District of Columbia, and Illinois—provided explicit statewide support for plant-based meal options. The remaining 48 jurisdictions (94.1%) did not explicitly promote or support plant-based meals in official statewide school nutrition policies or guidance. No jurisdiction mandated the frequency of plant-based meal offerings, although the District of Columbia provided non-binding guidance encouraging regular inclusion. Conclusions: Explicit statewide support for plant-based or vegetarian school meals remains rare in the United States. Strengthening state-level policies and developing standardized guidance on the inclusion and frequency of plant-based meals in school lunch programs may represent a feasible population-level strategy to improve dietary quality and reduce future pediatric cardiometabolic risk.
- Open Access
- 2 May 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 28, 101659
Oral PCSK9 inhibitors for elevated LDL-C: A systematic review and meta-analysis of randomized trials
- 2 May 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 28, 101659
Open AccessOral PCSK9 inhibitors for elevated LDL-C: A systematic review and meta-analysis of randomized trials